Growth Metrics

Solid Biosciences (SLDB) Current Leases (2018 - 2026)

Quarterly results put Current Leases at $2.2 million for Q1 2026, up 99.64% from a year ago — trailing twelve months through Mar 2026 was $2.2 million (up 99.64% YoY), and the annual figure for FY2025 was $2.1 million, up 17.68%.

Solid Biosciences has reported Current Leases over the past 9 years, most recently at $2.2 million for Q1 2026.

  • Current Leases reached $2.2 million in Q1 2026 per SLDB's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Current Leases topped out at $2.2 million in Q1 2026 and bottomed at $353000.0 in Q3 2022.
  • Median Current Leases over the past 5 years was $1.8 million (2024), compared with a mean of $1.5 million.
  • The largest annual shift saw Current Leases surged 423.23% in 2023 before it plummeted 73.38% in 2024.
  • Over 5 years, Current Leases stood at $668000.0 in 2022, then skyrocketed by 177.69% to $1.9 million in 2023, then dropped by 3.67% to $1.8 million in 2024, then increased by 17.68% to $2.1 million in 2025, then rose by 4.04% to $2.2 million in 2026.
  • Business Quant data shows Current Leases for SLDB at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 83,991.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 720.00 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 45.66 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 2.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.19 Mn
Dec 31, 2025 2.10 Mn
Sep 30, 2025 2.03 Mn
Jun 30, 2025 1.94 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 1.79 Mn
Sep 30, 2024 1.72 Mn
Jun 30, 2024 1.72 Mn
Mar 31, 2024 496,000.00
Dec 31, 2023 1.86 Mn
Sep 30, 2023 1.85 Mn
Jun 30, 2023 1.85 Mn
Mar 31, 2023 1.86 Mn
Dec 31, 2022 668,000.00
Sep 30, 2022 353,000.00
Jun 30, 2022 412,000.00
Mar 31, 2022 984,000.00
Dec 31, 2021 1.26 Mn
Sep 30, 2021 226,000.00
Jun 30, 2021 220,000.00
Mar 31, 2021 214,000.00
Dec 31, 2020 208,000.00
Sep 30, 2020 1.93 Mn
Jun 30, 2020 197,000.00
Mar 31, 2020 1.80 Mn
Dec 31, 2019 1.74 Mn
Sep 30, 2019 181,000.00
Jun 30, 2019 176,000.00
Mar 31, 2019 178,000.00
Dec 31, 2018 173,000.00